Saving Lives, Saving Money: Dividends for Americans from Investing in Alzheimer Research
June 2004
Alzheimer's Association
Lewin contact: Lisa Alecxih
To measure the cost benefit of potential Alzheimer research on Medicare and Medicaid spending and disease prevalence, the Alzheimer's Association commissioned The Lewin Group to conduct an analysis of potential savings the U.S. could realize with major breakthroughs in Alzheimer research. The report of this analysis, entitled Saving Lives, Saving Money: Dividends for Americans from Investing in Alzheimer Research, was released on June 23, 2004. The study assumes that by 2010, researchers will find a way to delay the onset of Alzheimer's disease just as scientists have been able to delay the onset of congestive heart failure, and a way to slow the progression of Alzheimer's just as they have slowed the progression of Parkinson's disease.